Advertisement

SGRY

Surgery Partners, Inc.

Healthcare · USD

Set alert

Price alert · SGRY

All alert types
23.21 USD 0.00 0.00%
As of Oct 30, 2026 Extended hours 23.21 0.00%
Bid
23.22 × 2
Ask
23.23 × 2
23.19 Day range 23.25
11.49 52-week range 23.36
YTD
+50.23%
1 year
+4.74%
Open
23.24
Prev close
23.21
Mkt cap
2.99B
Vol
3.51M
Avg vol
3.33M
EPS
-0.69
P/E
0.00
Div yield
0.00%
More statistics
Low
23.19
High
23.25
Forward P/E
111.43
Beta
1.91
Short ratio
6.88
Inst. own
128.71%
Dividend
0.00
Ex-div date
Earnings
Nov 9, 2026
50-d avg
14.95
200-d avg
14.59
1y target
21.70

5D chart

Chart tools
Interval
SGRY five-day price chart22.923.023.223.323.4Oct 26Oct 27Oct 28Oct 29Oct 30

Key statistics

Market cap
2.99B
Enterprise value
8.66B
Trailing P/E
0.00
Forward P/E
111.43
PEG ratio
0.00
Price / sales
0.89
Price / book
1.80
EPS (TTM)
-0.69
Beta
1.91
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-2.63%
Revenue (TTM)
3.37B
Revenue growth
2.70%
Free cash flow
183.56M
Total cash
216.70M
Total debt
4.07B
Return on equity
2.32%
Shares outstanding
128.87M
Short % of float
21.69%
50-day average
14.95
200-day average
14.59

Analyst view

Consensus: buy

Buy
Price target (mean) 21.70 -6.5% downside
Target (low)
19.00
Target (mean)
21.70
Target (high)
23.50
Ratings (0m) 7 2 buy · 5 hold · 0 sell
  • Strong buy0
  • Buy2
  • Hold5
  • Sell0
  • Strong sell0

Next earnings

Nov 9, 2026

Expected Nov 9, 2026. Consensus EPS estimate 0.12467.

Earnings history

Financials — quick view

All financials
SGRY Revenue — quarterly 848.90M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
SGRY Net income — quarterly -15.00M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
SGRY EPS — quarterly -0.12
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

SGRY recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 9, 2026Sep 30, 20260.1089———
Aug 10, 2026Jun 30, 20260.057940.10+0.04+72.59%
May 5, 2026Mar 31, 2026-0.15-0.03+0.12+80.00%
Mar 2, 2026Dec 31, 20250.310.12-0.19-61.29%
Nov 10, 2025Sep 30, 20250.190.13-0.06-31.58%
Aug 5, 2025Jun 30, 20250.160.17+0.01+6.25%

Upgrades / downgrades

SGRY analyst upgrades and downgrades
DateFirmActionFromTo
Oct 28, 2026UBSdownBuyNeutral
Oct 27, 2026StoneXdownBuyHold
Sep 30, 2026RBC CapitalreitOutperformOutperform
Sep 18, 2026TD CowenreitBuyBuy
Sep 14, 2026JP MorganmainNeutralNeutral
Aug 11, 2026TD CowenmainBuyBuy

About Surgery Partners, Inc.

Surgery Partners, Inc., together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery. It offers emergency departments; ancillary services such as physician practices and diagnostic testing; multi-specialty physician practices; urgent care facilities; and anesthesia services. In addition, it offers single- and multi-specialty facilities. Surgery Partners, Inc. was founded in 2004 and is headquartered in Brentwood, Tennessee.

Sector
Healthcare
Industry
Medical Care Facilities
Country
United States

News

Your note

Sign in to keep a note on SGRY — it syncs with the Stock Master app.

Insider holders

SGRY insider holders
InsiderRelationLatest transactionDateShares held
BALDOCK JENNIFER BOYDOfficerSaleMar 11, 2026326,474
BANE HARRISON ROfficerSaleSep 3, 2025117,181
BRITTENHAM MARISSAOfficerSaleMar 12, 202694,196
BURKHALTER DANIELLEOfficerSaleMar 12, 202676,864
DEVEYDT WAYNE SOfficer and DirectorStock Award(Grant)Mar 20, 2025105,203
DOHERTY DAVID T.Chief Financial OfficerSaleMar 15, 2026221,679

Institution ownership

SGRY institution ownership
Holder% heldSharesValueReported
Bain Capital Investors Llc38.15%49,946,9721.16BJun 29, 2026
Jupiter Topco LLC10.60%13,882,155322.00MJun 29, 2026
Pentwater Capital Management Lp8.88%11,630,000269.76MJun 29, 2026
UBS Group AG6.55%8,573,413198.86MJun 29, 2026
Blackrock Inc.4.77%6,241,503144.77MJun 29, 2026
King Street Capital Management, LP4.63%6,058,141140.52MJun 29, 2026

Fund ownership

SGRY fund ownership
Holder% heldSharesValueReported
JANUS INVESTMENT FUND-Janus Henderson Contrarian Fund10.13%13,258,236307.52MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund1.90%2,481,03457.55MJun 29, 2026
T. Rowe Price Small-Cap Stock Fund, Inc.1.60%2,097,59048.65MJun 29, 2026
iShares Trust-iShares Russell 2000 ETF1.58%2,063,09047.85MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund1.37%1,798,43941.71MJun 29, 2026
Legg Mason Partners Investment Trust-ClearBridge Select Fund1.22%1,594,77436.99MJul 30, 2026
Advertisement